Aspen agrees to buy GSK drugs for $967 million

JOHANNESBURG, Sept 30 Mon Sep 30, 2013 7:19am EDT

Related Topics

JOHANNESBURG, Sept 30 (Reuters) - South Africa's Aspen Pharmacare said on Monday it had agreed to a price of 600 million pounds ($967 million) to buy thrombosis drugs and a factory from shareholder GlaxoSmithKline.

Aspen and Britain's Glaxo first announced the deal in June.